Italfarmaco Türkiye (ITF Pharma), the Turkish affiliate of the global Italfarmaco Group, has announced the appointment of Selim Özyılmaz as its new General Manager.
In his new role, Özyılmaz will lead the company’s growth strategy in Türkiye, aiming to enhance access to innovative pharmaceutical products for healthcare professionals and patients.
Strategic Leadership for Growth
Throughout his career, Özyılmaz has held key leadership roles in strategy, sales, marketing, and general management within the pharmaceutical industry. He is recognized for his commercial success and strategic leadership approach.
The company aims to combine Italfarmaco’s global expertise with the dynamics of the Turkish market, further strengthening its local presence.
Focus Areas: Women’s Health and Neurology
Italfarmaco Türkiye has a strong position in the healthcare sector, particularly in women’s health and neurology, supported by a robust portfolio that also includes rare disease treatments.
